My Path to Quit Tobacco

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Wisconsin, Madison

About this trial

The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.

Eligibility criteria

Qualifiers

self-identify as Black

smoke cigarettes (greater than or equal to 1 cigarette on greater than or equal to 4 days/week)

motivated to quit smoking

willing to discontinue any non-study smoking cessation pharmacotherapy use during study treatment.

Disqualifiers

currently taking bupropion for non-smoking cessation reasons

Trial design

Treatments tested in this trial

  • Nicotine patch
  • Quitline Counseling Phone Calls
  • Counseling Sessions
  • Pathways to Freedom
  • Monetary Incentive

Treatment groups

1,550 Participants
are divided into 3 treatment groups

Sponsors and collaborators

University of Wisconsin, Madison

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator